Amring Pharmaceuticals recalls

FDA enforcement reports naming Amring Pharmaceuticals Inc as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Jun 21, 2023

Severity

Jun 21, 2023Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufact…Drug · Amring Pharmaceuticals IncFailed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.Class III